Technology Transfer at U-M Accelerating the commercialization of - - PowerPoint PPT Presentation

Technology Transfer at U-M

KELLY SEXTON Associate Vice President for Research Technology Transfer and Innovation Partnerships PETER FALZON President and CEO Ripple Science

Accelerating the commercialization of research discoveries and catalyzing startup success

1

“Let’s redefine how world-class university research can fuel a region and solve the world’s greatest challenges.”

2

The University of Michigan has the largest research voume of any public university in the country.

Source: National Science Foundation IN ANNUAL RESEARCH EXPENDITURES FY 2019

$1.6B

The University of Michigan’s Innovation Engine

3

This research enterprise is an engine of discovery. Technology Transfer is the process by which we move these innovations out

• f the lab and into the marketplace.

4

Capital Innovation Talent To launch successful startup companies, we need:

5

Talent

Talent Mentors-in-Residence

6

CA, MA and NY account for 75% of all VC invested in the US

Capital: Regional funding disparities create challenges for Michigan startups

Capital: Regional funding disparities create challenges for Michigan startups

Average Time from Founding to $500K Raised

by US Region

7 Years

“The Mentor in Residence program was my introduction to the Michigan entrepreneurship ecosystem. I was immediately impressed with the quality

• f the technology coming out of our
• universities. Within a year, I returned

full time from California to become an investor and entrepreneur in Michigan.”

MEDC SUPPORTED MENTOR IN RESIDENCE

From Michigan to Silicon Valley and back in 25 short years.

Our vision is to reduce clinical trial failures by 50%

Our technology transforms the patient enrollment and retention experience, the #1 reason cited when clinical trials fail.

ABOUT RIPPLE SCIENCE

❏ Launched Ripple in 2017 ❏ 22 jobs created ❏ $7 million capital raised ❏ $3 million from outside Michigan ❏ MEDC programs played a critical role

❏ Invest Detroit, Invest Michigan, Michigan Rise, Renaissance Ventures

THE “FIRST CAPITAL GAP”

❏ First capital is critical to get a product out the door ❏ “On the coasts” angels who have sold businesses tend to fill this role ❏ “Middle-state” angels tend to be later stage investors ❏ State funded programs fill the “first capital gap” in middle states ❏ Michigan’s MEDC funded programs are critical to level the playing field

RIPPLE DURING COVID

❏ Usage increased across-the-board when research teams went remote ❏ Ripple enables both remote team work and virtual patient monitoring ❏ Ripple is new technology being used to accelerate COVID clinical trials:

❏ US clinical trial to validate a point-of-care rapid COVID antibody test kit ❏ One of the five vaccine trials worldwide in human clinical trial stage of development ❏ And others ...

❏ Crisis catalyzes change. Technology enables that change.